Literature DB >> 7306924

Plasma prolactin levels in patients with breast cancer.

D P Rose, B T Pruitt.   

Abstract

The plasma prolactin levels of 98 healthy women 22 to 65 years old showed a strong inverse correlation with age. This relationship persisted for older premenopausal and postmenopausal women (aged 30 to 65 years) whose results were compared with those of 34 premastectomy early breast cancer patients, another 38 studied four to six weeks after mastectomy, and 38 with advanced disease (age range, 30 to 77 years). There was no correlation between age and plasma prolactin in any of the breast cancer groups. When patients and controls were classified according to their menopausal status, the premastectomy and postmastectomy early breast cancer groups both showed significantly higher prolactin concentrations than the corresponding controls (P less than 0.001) in all cases). These abnormalities were particularly prominent in the patients studied after surgery, although the difference was significant only for the postmenopausal groups (P less than 0.05). Plasma cortisol and urinary free cortisol levels were normal in postmastectomy patients, suggesting that stress was not the cause of elevated prolactin levels. In advanced breast cancer, elevated plasma prolactin concentrations were found only in the postmenopausal patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306924     DOI: 10.1002/1097-0142(19811215)48:12<2687::aid-cncr2820481221>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Intracystic Papillary Carcinoma of the Breast in Males. In Search of the Optimal Treatment for this Rare Disease.

Authors:  Michael Stamatakos; Charikleia Stefanaki; Theodora Stasinou; Evaggelia Papantoni; Ioannis Alexiou; Konstantinos Kontzoglou
Journal:  Breast Care (Basel)       Date:  2011-09-26       Impact factor: 2.860

Review 2.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 3.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

4.  Plasma and tumor prolactin in colorectal cancer patients.

Authors:  Y Ilan; O Sibirsky; N Livni; O Gofrit; V Barack; E Goldin
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

5.  Breast cancer in a male patient with prolactinoma.

Authors:  S Haga; O Watanabe; T Shimizu; T Iida; H Imamura; T Kajiwara; M Fujibayashi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

6.  Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.

Authors:  C V Clevenger; W P Chang; W Ngo; T L Pasha; K T Montone; J E Tomaszewski
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

Review 7.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

8.  Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.

Authors:  P R Maddox; D L Jones; R E Mansel
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

9.  A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Authors:  Sulggi A Lee; Christopher A Haiman; Noel P Burtt; Loreall C Pooler; Iona Cheng; Laurence N Kolonel; Malcolm C Pike; David Altshuler; Joel N Hirschhorn; Brian E Henderson; Daniel O Stram
Journal:  BMC Med Genet       Date:  2007-12-01       Impact factor: 2.103

10.  From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents.

Authors:  A Corbin
Journal:  Yale J Biol Med       Date:  1982 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.